Skip to main content
Terug
Watch Compare

Bio Green Med Solution, Inc.

Datakwaliteit: 100%
Ook genoteerd als BGMSP NASDAQ
BGMS
NASDAQ Manufacturing Chemicals
€ 1,04
€ 0,00 (0,00%)
6 months return
—
Momentum
Neutral
ROE
-55,90%

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-55,90%
Onder sectorgemiddelde (-54,68%)
ROIC-123,32%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio6,43
Interest Coverage-135,92

Waardering

PE (TTM)
-1,86
Onder sectorgemiddelde (-1,49)
P/B Ratio0,79
EV/EBITDAN/A
Dividend Yield3564,36%

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -4,77 M
Dividend yield of 3564,36% — meaningful income

Price History

Financiële Trends

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstverassingen

EPS
Reported Estimate
Q42023 Q12024 Q22024 Q32024
Reported -€ 1.495,20 -€ 544,80 -€ 172,80 -€ 43,20
Estimate -€ 1.524,00 -€ 1.183,20 -€ 344,40 -€ 129,60
Verrassing +1,89% +53,96% +49,83% +66,67%

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -55,90% · Net Margin: N/A
Revenue (TTM) 0,0 Net Income (TTM) -3,00 M
ROE -55,90% ROA -47,74%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -4,77 M
ROIC -123,32% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 6,43
Debt / Equity N/A Current Ratio 6,43
Interest Coverage -135,92 Asset Turnover 0,00
Working Capital 5,44 M Tangible Book Value 5,53 M

Dividends

Yield: 3564,36% · Payout: N/A
Dividend Yield 3564,36% Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years 1 yrs

Valuation

P/E: -1,86 · EV/EBITDA: N/A
P/E Ratio -1,86 Forward P/E N/A
P/B Ratio 0,79 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -85,57%
Market Cap 5,57 M Enterprise Value 1,74 M

Per Share

EPS: -6,45 · FCF/Share: -0,86
EPS (Diluted TTM) -6,45 Revenue / Share 0,00
FCF / Share -0,86 OCF / Share -0,86
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 159,11% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 159,11%
SBC-Adj. FCF -6,65 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 — — — —
Net Income -3,00 M -11,21 M -22,56 M -21,20 M -18,89 M
EPS (Diluted) -6,45 -2,09 -27,24 -1,90 -2,14
Gross Profit — — — — —
Operating Income -8,43 M -12,00 M -25,45 M -27,66 M -22,94 M
EBITDA — — — — —
R&D Expenses 848.000,0 6,66 M 19,16 M 20,27 M 15,48 M
SG&A Expenses — 5,39 M 6,72 M 7,38 M 7,46 M
D&A — — — — —
Interest Expense 62.000,0 — — — —
Income Tax 7.000,0 -782.000,0 -3,00 M -4,72 M -3,85 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8,19 M 4,09 M 8,81 M 27,50 M 42,59 M
Total Liabilities 1,34 M 6,27 M 8,20 M 7,50 M 5,32 M
Shareholders' Equity 6,84 M -2,17 M 607.000,0 15,51 M 37,26 M
Total Debt — — — — —
Cash & Equivalents 3,51 M 3,14 M 3,38 M 18,35 M 36,56 M
Current Assets 6,26 M 3,67 M 7,44 M 24,41 M 40,94 M
Current Liabilities 1,33 M 6,27 M 8,16 M 7,39 M 5,29 M

Sectorvergelijking

vs Manufacturing sector mediaan (1605 peers)
Metriek Aandeel Sector Mediaan
P/E -1,9 -1,5
P/B 0,8 1,6
ROE % -55,9 -54,7
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Dividendgeschiedenis

Rendement

3564,36%

Uitkeringsratio

N/A

Groei (3 jr)

N/A

Groei (5 jr)

N/A

Recente betalingen per aandeel (nieuwste eerst).

Ex-dividend Betaling Bedrag / aandeel
Apr 29, 2025 — € 36,00